BNP Paribas Financial Markets
DAWN

BNP Paribas Financial Markets’s Day One Biopharmaceuticals DAWN Stock Holding History

BNP Paribas Financial Markets’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.24M Sell
337,767
-115,544
-25% -$1.63M ﹤0.01% 1763
2025
Q4 		$4.22M Buy
453,311
+185,023
+69% +$1.55M ﹤0.01% 2156
2025
Q3 		$1.89M Buy
268,288
+142,826
+114% +$983K ﹤0.01% 2648
2025
Q2 		$816K Sell
125,462
-36,542
-23% -$251K ﹤0.01% 3039
2025
Q1 		$1.28M Buy
162,004
+125,319
+342% +$1.35M ﹤0.01% 2603
2024
Q4 		$465K Buy
+36,685
New +$510K ﹤0.01% 3354

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BNP Paribas Financial Markets's DAWN Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Day One Biopharmaceuticals (DAWN) stake by 25% in Q1 2026, selling an estimated $1.63M and leaving 337,767 shares worth $7.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

BNP Paribas Financial Markets first reported a position in DAWN in Q4 2024 and has held it in 6 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • BNP Paribas Financial Markets held 337,767 shares of Day One Biopharmaceuticals worth $7.24M as of Q1 2026.
  • BNP Paribas Financial Markets sold 115,544 Day One Biopharmaceuticals shares in Q1 2026, an estimated $1.63M.
  • Day One Biopharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1763 holding.
  • BNP Paribas Financial Markets first reported a position in Day One Biopharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.